1 Minute Read by Reuters Staff Reuters, JOHANNESBURG, June 30 – Aspen Pharmacare, a South African pharmaceutical business, announced on Wednesday that it has received a loan of 600 million euros ($711.84 million) from international financial institutions to assist restructure current loans and research vaccines. The loan will “refinance existing debt and enhance the company’s balance sheet, supporting Aspen’s operations, particularly vaccine production,” according to the International Finance Institution (IFC), the World Bank’s private sector arm. Aspen is obtaining COVID-19 vaccine ingredients from Johnson & Johnson in order to fill and finish the vaccines in South Africa. (1 dollar = 0.8429 euros) (Promit Mukherjee contributed to this report.) Jane Merriman edited the piece.)/n
Read More
